Original document(9 pages) Authorized document(10 pages) 中文版
    The invention provides a medicinal capsule for treating gynecological inflammation and its preparation process, wherein the capsule is prepared from (by weight ratio) honeysuckle flower 10 parts, capsule of weeping forsythia 5-7 parts, astragalus root 11-13 parts, bark of peony root 4-5 parts, radix isatidis 5-7 parts, wild chrysanthemum 5-7 parts, licorice 1-3 parts.
Application Number
申请号		 200410011221 Application Date
申请日		 2004.11.15
Title 名称 Medicinal capsule for treating gynecological inflammation and its preparation process
Publication Number
公开号		 1631414 Publication Date
公开日		 2005.06.29
Approval Pub. Date 2007.08.29 Granted Pub. Date 2007.08.29
International Classification 分类号 A61K36/906;A61K36/71;A61K36/634;A61K36/484;A61K36/481;A61K36/35;A61K36/28;A61K36/19;A61K9/48;A61P15/00
Applicant(s) Name
申请人		 Changchun Jinlai Pharmaceutical(Group) Co., Ltd.
Address 地址
Inventor(s) Name 发明人 Wang Jianying;Ren Yanmei;Zhang Hong
Attorney & Agent 代理人 wang enyuan

  
Control device for automatic light change of automobile front lamp
Capsule for treating prostate disease and its preparing process
Composition for improving life quality of cancer patients
Medicine for treating broken tendon and trauma and preparing process thereof
Chinese medicinal formulation for treating enuresis and urinary incontinence
Medicine for treating chronic ulcerative colitis and its preparation process
Phacellanthus extractive, its preparation and medical application
Refined puncturevine fruit saponin capable of being administered by injection, its preparing process and injecta
Medicine for treating teen-ager's leukotrichia
Application of violet gold extractive in preparing process of medicine for resisting virus and bacteria
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.